The nocturia market size was valued at USD 3.57 Billion in 2025, driven by the rising prevalence of nocturia across the 8 major markets. The market is expected to grow at a CAGR of 8.30% during the forecast period of 2026-2035, with the values likely to rise USD 7.92 Billion by 2035.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
8.3%
Value in USD Billion
2026-2035
*this image is indicative*
Nocturia is a medical condition characterized by excessive urination at night, with the affected individual visiting the bathroom twice or more at nighttime. Patients with nocturia can suffer from sleep deprivation which can greatly impact the quality of life. It is also linked with obesity, depression, diabetes, and heart disease, among others.
The market is driven by the rising prevalence of nocturia, with over 50% of men and women aged 60 or more reported to be diagnosed with the condition. The incidence of nocturia in older men is higher than in older women, amounting to 50% in men between 70 to 79 years having two or more nightly voids. The growing number of patients with nocturia is expected to directly drive the nocturia market demand, with more and more individuals seeking effective treatment options to manage the symptoms.
As people age, they are more likely to experience nocturia, which also tends to become more severe. With the rising geriatric population, clinically significant nocturia cases are expected to surge. According to the United Nations Population Fund, the number of older people aged 60 years, or more is expected to reach 2.1 billion worldwide, accounting for 22% of the total population. Moreover, it is estimated that the elderly population in India will double, almost reaching 347 million in 2050. This indicates that the rapid growth of the geriatric population is likely to augment nocturia market share in the coming years.
The market is also supported by increased research initiatives aimed at finding innovative treatment solutions to treat nocturia. In April 2023, a randomized controlled trial revealed the potential of Erbium YAG laser treatment to manage overactive bladder, often accompanied by frequent urination and nocturia. The study showed positive results, with women receiving the intervention reporting less nocturia and urination urgency, along with additional benefits. The development of such novel treatment methods is anticipated to boost nocturia market growth.
Other factors that impact the market dynamics include the growing technological advancements in diagnostic tools and digital health applications for monitoring symptoms and treatment efficacy. Rising healthcare expenditure, and the introduction of advanced therapies also impact the market significantly. Moreover, the market is expected to witness increased demand owing to the high prevalence rate of chronic conditions such as obesity and hypertension that make an individual prone to nocturia.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Nocturia Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Disease Type
The market is segmented by disease type into polyuria, nocturnal polyuria, low nocturnal bladder capacity, and mixed nocturia. In about 88% of patients , the cause of nocturia is nocturnal polyuria which is characterized by greater production of urine during nighttime.
Market Breakup by Drug Type
In terms of drug type, the market comprises anti-cholinergic drugs, desmopressin, antibiotics, anti-spasmodic, and other medications targeting various aspects of nocturia management. This market segment reflects the range of medications usually prescribed for treating nocturia. For instance, desmopressin is an antidiuretic that is usually given to nocturia patients to reduce the amount of urine produced.
Market Breakup by Dosage Form
The nocturia market share by dosage forms includes tablets and nasal sprays. This segment offers different administration options according to specific patient needs and convenience.
Market Breakup by Distribution Channel
Distribution channels for nocturia drugs are hospital pharmacies, drug stores, retail pharmacies, and online pharmacies. This segment provides various facilities or healthcare settings for patients to access medications.
Market Breakup by Region
Based on the region, the nocturia market segmentation includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. United States holds a significant portion of the market which can be attributed to the high prevalence rate of the disease in the region. It is estimated that 50 million individuals are affected by the condition, which can severely impact the overall health and daytime functioning of the patient. The rising number of nocturia cases along with heightened patient awareness and diagnostic rates are expected to drive the market demand in the regional market.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Disease Type |
|
| Breakup by Drug Type |
|
| Breakup by Dosage Form |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share